{"id":"W2746712977","doi":"10.1016/j.ctrv.2017.08.001","title":"Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trastuzumab; Hazard ratio; Internal medicine; Breast cancer; Oncology; Meta-analysis; Confidence interval; Randomized controlled trial; Odds ratio; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009649669,0.001215642,0.05782837,0.0004775849,0.00007097647,0.00006022476,0.0004384814,0.0003032298,0.0007922301],"category_scores_gemma":[0.0108135,0.0005798434,0.00973872,0.0002701691,0.0004014415,0.0001335484,0.0001017975,0.0003527837,0.000004915592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001699879,"about_ca_system_score_gemma":0.00425593,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03449089,"about_ca_topic_score_gemma":0.002448242,"domain_scores_codex":[0.9792472,0.009826184,0.008294339,0.001184827,0.001003228,0.0004442224],"domain_scores_gemma":[0.9821563,0.005651302,0.009186146,0.002048348,0.000440421,0.00051751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1178487,0.0005336195,0.00004376716,0.01294347,0.05549614,0.00007698745,0.0001673059,0.000002605224,0.000009114387,0.00001543902,0.0007273498,0.8121355],"study_design_scores_gemma":[0.3648906,0.0002957665,0.000211711,0.06198465,0.3674256,0.000006400198,0.000009171366,0.00002367731,0.00002269627,0.00007250869,0.2045724,0.0004848409],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004872499,0.9494011,0.00000789157,0.0008526279,0.0002765507,0.02342404,0.02562312,0.00001163664,0.0003543205],"genre_scores_gemma":[0.0003002801,0.9814419,0.0001107868,0.00003126906,0.000446204,0.01546219,0.001305284,0.00007844279,0.0008236266],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8116507,"threshold_uncertainty_score":0.9996653,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4789733859490883,"score_gpt":0.54750043717925,"score_spread":0.06852705123016167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}